Atlas Trials

Kidney Damage in Patients Receiving Cisplatin and Ifosfamide for Solid Tumors

Clinical trial NCT00695032 · SUSPENDED

Trial details

NCT number
NCT00695032
Sponsor
Institut Claudius Regaud
Status
SUSPENDED
Phase
Not Applicable
Study type
INTERVENTIONAL
Chemotherapeutic Agent ToxicityRenal ToxicityUnspecified Adult Solid Tumor, Protocol Specific
Start date
2007-10-01
Primary completion
2012-09-01
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.